ADMA BIOLOGICS INC (ADMA:NASDAQ)
$9.23 -0.16 (-1.7039%)
Analysed ADMA BIOLOGICS INC (ADMA:NASDAQ) News Sources
ADMA Biologics (ADMA) Faces Class Actions And Probes Over Revenue Allegations
15-07-2026
yahoo.com
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
27-07-2026
yahoo.com
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?
29-07-2026
yahoo.com
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note
31-07-2026
yahoo.com
ADMA Biologics Q2 Earnings Call Highlights
05-08-2026
marketbeat.com
ADMA Biologics Inc (ADMA) (Q2 2026) Earnings Call Highlights: Ascentiv Surges 24% as Gross ...
06-08-2026
yahoo.com
Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?
04-09-2026
yahoo.com
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
08-09-2026
yahoo.com
Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know
10-09-2026
yahoo.com
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
11-09-2026
yahoo.com
What is the current price of ADMA BIOLOGICS INC (ADMA:NASDAQ)?
The current price of ADMA BIOLOGICS INC (ADMA:NASDAQ) is $9.23.
ADMA BIOLOGICS INC (ADMA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ADMA BIOLOGICS INC (ADMA:NASDAQ) since the previous trading day is $-0.16.
ADMA BIOLOGICS INC (ADMA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ADMA BIOLOGICS INC (ADMA:NASDAQ) since the previous trading day is -1.7039%.
What is the most recent average sentiment score for ADMA BIOLOGICS INC (ADMA:NASDAQ)?
The most recent average sentiment score for ADMA BIOLOGICS INC (ADMA:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for ADMA BIOLOGICS INC (ADMA:NASDAQ)?
The most recent sentiment for ADMA BIOLOGICS INC (ADMA:NASDAQ) is .
SEC-8K** Filing Available For ADMA BIOLOGICS INC (ADMA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.